Tag: Silence Therapeutics stock
Recent Posts
- Suncorp SUNPH Redemption Update Shakes ASX Market
- Auric Mining Expands Munda Gold Resource by 32% as Starter Pit Outperforms Expectations
- Commonwealth Bank of Australia Raises EUR 1.25 Billion Through Subordinated Notes
- Future Generation Global Board Update Announcement
- How CFS Retirement Products Work With Generation Life Solutions
- QBE AT1 Capital Update for Wholesale Investors
- Bellevue Gold Hits a Major Milestone as Deacon North Delivers First Ore on Schedule at the 2026 Mining Conference
- BRE Announces Amargosa Spin-Off to Alurion Resources
- Gareth Solly Takes the Helm as CEO; Auric Mining Is a Step Closer to “Becoming WA’s Next Fully Integrated Mining House”
- TotalEnergies Walks Away from US Offshore Wind to Double Down on LNG
- British Steel Is One Step Closer to Public Hands – Here’s What the King’s Speech Bill Really Means
- The Woolworths Worker Told to Cover His Plumber’s Crack Just Lost His Unfair Dismissal Claim
- PayPal Reports Q1 2026 Earnings Beat, Plans 20% Workforce Reduction Under New CEO
- West Dome Underground Delivers Strong Hit At Telfer
- Dateline Resources BFS Confirms Strong Economics at the Colosseum Gold Project
- Two ASX Dividend Stocks Offering Strong Yield Potential in 2026
- Two ASX Shares Experts Are Highly Recommending to Buy Right Now
- MV Hondius Hantavirus Outbreak: Australians Return Home After Tenerife Evacuation
- Australia’s Dying Middle Class: The Rise of an Inherited Wealth Nation
- These Lithium Stocks Are Sitting on Some of the World’s Rarest Cesium Assets
- Aeris High-Grade Copper Results Strengthen Tritton Growth Outlook
- CSL Interim CEO Review Flags FY26 Financial Update
- Elevra Lithium Cashes Out of Ewoyaa as Huayou Sweeps Up Ghana’s Lithium Future
- Cornish Metals Secures $210 Million Bond to Revive South Crofty Tin Mine
- Two Vanguard ETFs on the ASX That Could Strengthen Any Long-Term Portfolio This May
- Inside Warren Buffett’s 70-Year Wealth-Building Journey: How to Grow Wealth in Any Market
- Australia Tightens Crypto Rules as AUSTRAC Targets Firms Ahead of 2026 Deadlines
- Lynx Equity Picks Intel Over AMD as Apple Chip Deal Reshapes the AI Chip Race
- Alphabet Stock Forecast Strengthens After Q1 Double-Beat
- Moderna Stock Climbs to Two-Month High on Hantavirus Vaccine Development News
Categories
Disclaimer
COLITCO LLP accepts no responsibility for any claim, loss or damage as a result of information provided or its accuracy. The information provided on this site is general in nature, not financial product advice, see a financial expert before making any investment decision. Your personal objectives, financial situation or needs have not been taken into consideration. There may be a conflict of interest present with commercial arrangements with companies and/or stock held. COLITCO LLP or an associate may receive a commission for funds raised.